An activist shareholder group aptly named Hope for MannKind has gone public with a campaign to reform the marketing strategy for Afrezza, an inhalable form of insulin and the only commercial product of MannKind Corp. in Westlake Village....

Subscribe to get the full story.


Are you a subscriber? Sign In